why choose us

First received: June 14, 2023

Clinical Trial: Whole Blood Biospecimen Collection for Subjects With Chronic Granulomatous Disease (CGD)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Chronic Granulomatous Disease

Study Type: OBSERVATIONAL


Official Title: Whole Blood Biospecimen Collection for Subjects With Chronic Granulomatous Disease (CGD)

Brief Summary: The primary study objective is to collect biospecimen samples (e.g., blood) from participants diagnosed with Chronic Granulomatous Disease (CGD).The biospecimens will be used to create a biorepository that can be used to identify disease associated biomarkers and potential targets with immune and multi-omics profiling.The disease sample collection and analysis will be the foundation for an extensive network of biospecimen access and linked datasets for future translational research.

Read more